Taiwan Land Development Corp (TLDC, 台灣土地開發) is venturing into the healthcare business by partnering with a hospital to set up a medical mall in Hualien.
The Taipei-based developer has inked a memorandum of understanding with Hualien Tzu Chi Hospital (花蓮慈濟醫院) to tap into the healthcare and preventive medicine businesses, in the face of an aging population.
“The pact will allow the two sides to cooperate in digital health management, anti-aging, preventive medicine, regenerative medicine, cell therapy and other aspects,” TLDC chairman Chiu Fu-sheng (邱復生) told reporters after the signing ceremony in Taipei on Friday.
The ultimate goal is to build a world-class biotechnology park in Hualien that can help keep people healthy without dependence on medicine, Chiu said.
In the first stage of cooperation, Tzu Chi Hospital is to help TLDC build a digital health management platform using information and data from the hospital, he said.
In the second stage, Tzu Chi is to lend support in the creation of a medical mall that offers spa treatments, drug stores, skin care products, aesthetic procedures and other services at a mixed-use complex called New Paradiso (新天堂樂園) II, TLDC said.
The medical mall is to occupy the lower floors of a 10-story building, while the upper floors are to serve as a budget hotel space under the Ibis brand, it said.
Hualien Tzu Chi is to share its knowhow and help recruit interested parties to set up operations in the medical mall, TLDC said.
TLDC added that it is stepping up efforts to fill retail space at New Paradiso I, which currently features a shopping mall, top-grade movie theaters and a container turned into a Starbucks outlet.
The latest additions include South Korean coffee cup vendor Luycho Inc and Taipei-based Chinese restaurant Ding Fu Lou (鼎富樓).
Paradiso I and II are parts of a massive development project at Hualien Bay (洄瀾灣), which includes residential apartments and assorted recreational facilities.
Taiwan’s exports soared 56 percent year-on-year to an all-time high of US$64.05 billion last month, propelled by surging global demand for artificial intelligence (AI), high-performance computing and cloud service infrastructure, the Ministry of Finance said yesterday. Department of Statistics Director-General Beatrice Tsai (蔡美娜) called the figure an unexpected upside surprise, citing a wave of technology orders from overseas customers alongside the usual year-end shopping season for technology products. Growth is likely to remain strong this month, she said, projecting a 40 percent to 45 percent expansion on an annual basis. The outperformance could prompt the Directorate-General of Budget, Accounting and
Two Chinese chipmakers are attracting strong retail investor demand, buoyed by industry peer Moore Threads Technology Co’s (摩爾線程) stellar debut. The retail portion of MetaX Integrated Circuits (Shanghai) Co’s (上海沐曦) upcoming initial public offering (IPO) was 2,986 times oversubscribed on Friday, according to a filing. Meanwhile, Beijing Onmicro Electronics Co (北京昂瑞微), which makes radio frequency chips, was 2,899 times oversubscribed on Friday, its filing showed. The bids coincided with Moore Threads’ trading debut, which surged 425 percent on Friday after raising 8 billion yuan (US$1.13 billion) on bets that the company could emerge as a viable local competitor to Nvidia
CHIP RACE: Three years of overbroad export controls drove foreign competitors to pursue their own AI chips, and ‘cost US taxpayers billions of dollars,’ Nvidia said China has figured out the US strategy for allowing it to buy Nvidia Corp’s H200s and is rejecting the artificial intelligence (AI) chip in favor of domestically developed semiconductors, White House AI adviser David Sacks said, citing news reports. US President Donald Trump on Monday said that he would allow shipments of Nvidia’s H200 chips to China, part of an administration effort backed by Sacks to challenge Chinese tech champions such as Huawei Technologies Co (華為) by bringing US competition to their home market. On Friday, Sacks signaled that he was uncertain about whether that approach would work. “They’re rejecting our chips,” Sacks
BARRIERS: Gudeng’s chairman said it was unlikely that the US could replicate Taiwan’s science parks in Arizona, given its strict immigration policies and cultural differences Gudeng Precision Industrial Co (家登), which supplies wafer pods to the world’s major semiconductor firms, yesterday said it is in no rush to set up production in the US due to high costs. The company supplies its customers through a warehouse in Arizona jointly operated by TSS Holdings Ltd (德鑫控股), a joint holding of Gudeng and 17 Taiwanese firms in the semiconductor supply chain, including specialty plastic compounds producer Nytex Composites Co (耐特) and automated material handling system supplier Symtek Automation Asia Co (迅得). While the company has long been exploring the feasibility of setting up production in the US to address